Diagnosis and Management of Nonalcoholic Fatty Liver Disease

Peggy B Leung; Andrew M Davis; Sonal Kumar

doi:10.1001/jama.2023.17935

Diagnosis and Management of Nonalcoholic Fatty Liver Disease

JAMA. 2023 Nov 7;330(17):1687-1688. doi: 10.1001/jama.2023.17935.

Authors

Peggy B Leung¹, Andrew M Davis², Sonal Kumar³

Affiliations

¹ Division of General Internal Medicine, Weill Cornell Medicine, New York, New York.
² Section of General Internal Medicine, University of Chicago, Chicago, Illinois.
³ Division of Gastroenterology and Hepatology, Department of Medicine, NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York.

PMID: 37843854
DOI: 10.1001/jama.2023.17935

No abstract available

Plain language summary

This JAMA Clinical Guidelines Synopsis summarizes the American Association of Clinical Endocrinology’s 2022 clinical practice guideline for diagnosis and management of nonalcoholic fatty liver disease.

MeSH terms

Humans
Liver
Non-alcoholic Fatty Liver Disease* / diagnosis
Non-alcoholic Fatty Liver Disease* / therapy